Founded in 1986, the Norwegian subsidiary of Thermo Fisher Scientific (former Dynal Biotech) has 30 years experience in developing monosized, superparamagnetic and non-magnetic beads. The company has 180 employees and operates in the diagnostics market and development of innovative immunotherapeutics, especially within oncology. In addition, the company is active in areas like Research and Next Gen Sequencing. The client portfolio features many of the world’s largest pharma and diagnostics companies.
The company is complying with ISO 9001:2008 and ISO 13485:2012, and follows the requirements of cGMP. Furthermore, our quality system is based on customer requirements, enabling us to offer custom QA to support customers’ own GMP initiatives or local regulations.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.